Thrombotic thrombocytopenic purpura and pregnancy treated with fresh-frozen plasma infusions after plasmapheresis: A case report

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 7, 2007, Pages 689-690

  Ilter, Erdin ^a   Haliloglu, Berna ^a   Temelli, Figen ^a   Ozden, Selcuk ^a  

^a MALTEPE UNIVERSITY   (Turkey)

Author keywords

Frozen plasma infusion; Plasmapheresis; Pregnancy; Thrombotic thrombocytopenic purpura

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; ARTICLE; CASE REPORT; FATIGUE; FEMALE; HUMAN; LABORATORY TEST; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ADULT; CESAREAN SECTION; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PLASMA EXCHANGE; PLASMAPHERESIS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 34748903482     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3281eec98e     Document Type: Article

References (16)

1. Shamseddine A, Chehal A, Usta I, Salem Z, El-Saghir N, Taher A. Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature review. J Clin Apher 2004; 19:5-10.
2. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001; 98:1662-1666.
3. Furlan M, Robles R, Solenthaler M, Lämmle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 1998; 91:2839-2846.
4. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339:1585-1594.
5. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413:488-494.
6. Moake J, Chintagumpala M, Turner N, Mc Pherson P, Nolasco L, Steuber C, et al. Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura. Blood 1994; 84:490-497.
7. Furlan M, Lammle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol 2001; 14:437-454.
8. Castella M, Pujol M, Julia A, Massague I, Bueno J, Ramon Grifols J, Puig L. Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases. Vox Sang 2004; 87:287-290.
9. George JN. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 2003; 10:339-344.
10. Pritchard JA, Cunningham FG, Mason RA. Coagulation changes in eclampsia. Their frequency and pathogenesis. Am J Obstet Gynecol 1976; 126:855-864.
11. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325:393-397.
12. Häberle J, Kehrel B, Ritter J, Jürgens H, Lämmle B, Furlan M. New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review. Eur J Pediatr 1999; 158:883-887.
13. Barbot J, Costa E, Guerra M, Barreirinho MS, Isvarlal P, Robles R, et al. Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. Br J Haematol 2001; 113:649-651.
14. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000; 96:1223-1229.
15. Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 2003; 14:1072-1081.
16. Perdue JJ, Vesely SK, George JN, Clark KR, Terrell DR. Residual effects of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) on health-related quality of life (QOL): limitations in vitality and daily activities among survivors. Blood 2001; 98:62b-63b.